drugset / Trial / NCT05470998
L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to investigate the possible efficacy and safety of L-Arginine in children having Sickle Cell Disease with increased Tricuspid Regurgitant Jet Velocity
Timeline
- Start
- 2022-07-25
- Primary completion
- 2024-10-01
- Completion
- 2024-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-arginine | Small molecule | 0.1 g/kg | — |
| Comparator | L-arginine | Small molecule | 0.2 g/kg | — |
| Comparator | L-arginine | Small molecule | 1000 mg | — |